Mebane, NC, United States of America

Kingsley H Nelson, Jr

USPTO Granted Patents = 3 


Average Co-Inventor Count = 17.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Inventive Journey of Kingsley H Nelson, Jr

Introduction:

Kingsley H Nelson, Jr, a talented inventor based in Mebane, NC (US), has made significant contributions to the field of pharmaceuticals with his innovative patents. With a total of 3 patents to his name, his work focuses on developing solutions for chemokine-mediated diseases such as inflammatory disorders and cancer.

Latest Patents:

Nelson's latest patents revolve around compounds that serve as CXC-chemokine receptor ligands, aiding in the treatment of acute and chronic inflammatory conditions as well as cancer. These compounds, in the form of a formula or a pharmaceutically acceptable salt, offer promising prospects for patients battling these challenging health conditions.

Career Highlights:

Throughout his career, Nelson has showcased his expertise at renowned companies such as Schering Corporation and Pharmacopeia Drug Discovery, Inc. His work exemplifies a commitment to advancing the field of pharmaceuticals through groundbreaking inventions and innovative solutions.

Collaborations:

Nelson has had the privilege of collaborating with esteemed professionals in the field, including Arthur G Taveras and Cynthia J Aki. The collaborative efforts with these individuals have led to groundbreaking discoveries and advancements in the realm of pharmaceutical research.

Conclusion:

In conclusion, Kingsley H Nelson, Jr's dedication to innovation and his passion for developing solutions to combat chemokine-mediated diseases have solidified his standing as a prominent inventor in the pharmaceutical industry. With a proven track record of inventive prowess and a commitment to making a meaningful impact, Nelson continues to inspire and drive progress in the field of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…